Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase.
about
Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.Updates on the pathophysiology and management of acne rosacea.Hypersensitivity vasculitis with leukocytoclastic vasculitis associated with alpha-1-proteinase inhibitor.Reduction of matrix metalloproteinase 8-neutrophil collagenase levels during long-term doxycycline treatment of reactive arthritisEffect of scaling and root planing combined with systemic doxycycline therapy on glycemic control in diabetes mellitus subjects with chronic generalized periodontitis: a clinical study.Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: a proof of concept trial.The molecular pathology of rosacea.Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model.Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature.Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action.Tetracycline derivatives induce apoptosis selectively in cultured monocytes and macrophages but not in mesenchymal cells.Proteinase activity and receptor cleavage: mechanism for insulin resistance in the spontaneously hypertensive rat.The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study.Effect of non-surgical periodontal treatment with or without doxycycline on the periodontium of type 1 diabetic patients.Doxycycline treatment prevents alveolar destruction in VEGF-deficient mouse lung.
P2860
Q33183384-E05856A2-AB68-477B-9D41-015EFBCB8AAAQ33509787-E03E13B8-3D84-4ECA-8613-8215340E2507Q33692541-35B4E681-EB55-407A-8922-22980A01E483Q33750167-7FBC385E-057E-41EC-B13D-ACCEEF95A5E3Q36837441-5B291647-3576-44EB-8123-E36215C5B472Q36976237-BFB21E40-0FE0-49F4-BC9A-E335CBC1FF02Q37349837-FE64A6DA-9052-47C9-BDE5-302E17A53F61Q37385378-03DD503A-FCAC-4039-A073-4445AC43A96EQ37769021-1DD7C03A-062D-4D8E-A488-A05A6F20975EQ37800572-B337F607-5550-4B53-BE5C-4F4F09970A97Q40974308-D5789E9E-2864-4F8D-AAA3-26AA33B1DBD3Q43134563-D0BA7A6E-43C5-4E84-9C9D-0589236E0397Q45098129-B8862F59-F300-4F73-BA57-0CE8029D6389Q46584408-8767669B-AFB1-4603-9320-9EB5AFA0DE06Q52852244-82F7D40A-C648-48E9-BDC9-D83708EA5132
P2860
Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Doxycycline in the protection ...... il collagenase and gelatinase.
@ast
Doxycycline in the protection ...... il collagenase and gelatinase.
@en
type
label
Doxycycline in the protection ...... il collagenase and gelatinase.
@ast
Doxycycline in the protection ...... il collagenase and gelatinase.
@en
prefLabel
Doxycycline in the protection ...... il collagenase and gelatinase.
@ast
Doxycycline in the protection ...... il collagenase and gelatinase.
@en
P2093
P2860
P356
P1476
Doxycycline in the protection ...... il collagenase and gelatinase.
@en
P2093
K Suomalainen
Y T Konttinen
P2860
P304
P356
10.1128/AAC.37.3.592
P407
P577
1993-03-01T00:00:00Z